Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China; Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, China.
Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.
Am J Med Sci. 2023 Aug;366(2):87-95. doi: 10.1016/j.amjms.2023.04.024. Epub 2023 May 14.
Ferroptosis is a pervasive non-apoptotic mode of cell death that is different from autophagy or necrosis. It is mainly caused by an imbalance between the production and degradation of lipid reactive oxygen species in cells. Several metabolic pathways and biochemical processes, such as amino acid and lipid metabolism, iron handling, and mitochondrial respiration, affect and regulate cell sensitivity to peroxidation and ferroptosis. Organ fibrosis, a pathological manifestation of several etiological conditions, leads to chronic tissue injury and is characterized by excessive deposition of extracellular matrix components. Excessive tissue fibrosis can have diverse pathophysiological effects on several organ systems, eventually causing organ dysfunction and failure. The current manuscript provides a review that illustrates the link between ferroptosis and organ fibrosis and to better understand the underlying mechanisms. It provides novel potential therapeutic approaches and targets for fibrosis diseases.
铁死亡是一种广泛存在的非细胞凋亡性细胞死亡方式,不同于自噬或坏死。它主要是由细胞内脂质活性氧的产生和降解之间的失衡引起的。几种代谢途径和生化过程,如氨基酸和脂质代谢、铁处理和线粒体呼吸,影响和调节细胞对过氧化和铁死亡的敏感性。器官纤维化是几种病因条件的病理表现,导致慢性组织损伤,其特征是细胞外基质成分的过度沉积。过多的组织纤维化会对多个器官系统产生多种病理生理学影响,最终导致器官功能障碍和衰竭。本手稿提供了一篇综述,说明了铁死亡与器官纤维化之间的联系,并深入了解了潜在机制。它为纤维化疾病提供了新的潜在治疗方法和靶点。